GlassScriptPhysician profile
Lauren E Westcott
NPI 1922380161
$1,032.65
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $127 · 2022: $110 · 2023: $263 · 2024: $532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $795.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $323.98 | 2021-2024 | |
| Madrigal Pharmaceuticals | $205.45 | 2024 | Rezdiffra, Resmetirom |
| Regeneron Healthcare Solutions, INC. | $141.91 | 2023-2024 | Dupixent |
| Pfizer INC. | $83.32 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $75.71 | 2023-2024 | Entyvio |
| Ardelyx, INC. | $61.55 | 2023-2024 | Ibsrela |
| Access Pro Medical, LLC | $55.37 | 2022-2023 | Matriderm |
| Ferring Pharmaceuticals INC. | $25.48 | 2024 | Rebyota |
| Gilead Sciences, INC. | $22.42 | 2024 | |
| Intercept Pharmaceuticals, INC. | $19.39 | 2024 | |
| Medtronic, INC. | $18.07 | 2024 | Gi Genius |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Westcott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.